Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News AI used to predict future flares of ulcerative colitis activity Ulcerative colitis assessment could be improved after new research shows that an AI model could predict flare-ups and complications after reading biopsies.
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
25 June 2021 Congress focuses on impact of COVID-19 on global liver disease University of Birmingham experts are leading discussions at the 2021 International Liver Congress citing the effects of COVID-19 on people with liver disease.
11 June 2021 Fighting the silent pandemic of anti-microbial resistance An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.
04 June 2021 Study of UK dental professionals reveals extent of occupational risk of SARS-CoV-2 infection A University of Birmingham-led study of dental professionals has shown their increased risk of SARS-CoV-2 infection during the first wave of the pandemic.
04 June 2021 Study finds patients with COVID-19 produce immune responses against the body's own tissues or organs A University of Birmingham-led study has found that many patients with COVID-19 produce immune responses against their body's own tissues or organs.
14 May 2021 Study finds delaying second Pfizer vaccine to 12 weeks increases antibody responses in older people New study finds antibody responses in people over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer vaccine after 12 weeks.
12 May 2021 Study investigates immune response to SARS-CoV-2 infection in patients with antibody deficiencies A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs Latest research has found a new approach to tackling viruses by targeting the 'control centre' in viral RNA, leading to broad spectrum anti-viral drugs.